A Study of Andexanet Alfa in Patients Requiring Urgent Surgery or Procedure

Trial Identifier: D9604C00001
Sponsor: AstraZeneca
NCTID:: NCT05926349
Start Date: August 2024
Primary Completion Date: January 2027
Study Completion Date: September 2027

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

No locations posted.